Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
173 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
46 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Assessing COVID-19 Vaccine Effectiveness in Observational Studies via Nested Trial Emulation (2403.18115v1)

Published 26 Mar 2024 in stat.ME and stat.AP

Abstract: Observational data are often used to estimate real-world effectiveness and durability of coronavirus disease 2019 (COVID-19) vaccines. A sequence of nested trials can be emulated to draw inference from such data while minimizing selection bias, immortal time bias, and confounding. Typically, when nested trial emulation (NTE) is employed, effect estimates are pooled across trials to increase statistical efficiency. However, such pooled estimates may lack a clear interpretation when the treatment effect is heterogeneous across trials. In the context of COVID-19, vaccine effectiveness quite plausibly will vary over calendar time due to newly emerging variants of the virus. This manuscript considers a NTE inverse probability weighted estimator of vaccine effectiveness that may vary over calendar time, time since vaccination, or both. Statistical testing of the trial effect homogeneity assumption is considered. Simulation studies are presented examining the finite-sample performance of these methods under a variety of scenarios. The methods are used to estimate vaccine effectiveness against COVID-19 outcomes using observational data on over 120,000 residents of Abruzzo, Italy during 2021.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (4)
  1. Centers for Disease Control and Prevention. (2021) Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Available from: https://web.archive.org/web/20210527235512/https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html [Accessed 20th March 2024]
  2. Cox, D.R. (1958). Planning of experiments. New York: Wiley.
  3. World Health Organization (2022) The Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know. Available from: https://www.who.int/news-room/feature-stories/detail/the-oxford-astrazeneca-covid-19-vaccine-what-you-need-to-know [Accessed 20th March 2024]
  4. World Health Organization (2024) WHO Coronavirus (COVID-19) Dashboard. Available from: https://data.who.int/dashboards/covid19/cases?n=c [Accessed 20th March 2024]

Summary

We haven't generated a summary for this paper yet.

X Twitter Logo Streamline Icon: https://streamlinehq.com